Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.
|
19020799 |
2008 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
|
8246952 |
1993 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutations were identified in seven patients with CFC (two in BRAF, one in KRAS, one in MEK1, two in MEK2 and one in SOS1).
|
18456719 |
2008 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cardiofaciocutaneous Syndrome (CFCS) is a rare genetic syndrome caused by mutations in one of four genes: BRAF, MAP2K1, MAP2K2, and KRAS.
|
26842671 |
2016 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
|
20926413 |
2011 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline KRAS mutations were shown recently to be associated with developmental disorders, including Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS).
|
20949621 |
2011 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
|
17703371 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis revealed individual heterozygous mutations in the KRAS (phenotype of CFC/Noonan syndrome) and BRAF genes (phenotype of CFC syndrome).
|
21871821 |
2012 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In total, 35 of 56 (62.5%) patients with CFC syndrome had mutations (3 in KRAS, 24 in BRAF, and 8 in MAP2K1/2).
|
17366577 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
The cardiofaciocutaneous syndrome.
|
16825433 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
In conclusion, our data underscore the important role of RAS in the pathogenesis of the group of related disorders including NS, CFCS, and CS, and provide clues to the high phenotypic variability of patients with germline KRAS mutations.
|
20949621 |
2011 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome.
|
17551339 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder that is phenotypically similar to Noonan syndrome and is associated with mutations in BRAF, MEK1, MEK2, and KRAS.
|
31125963 |
2019 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We performed detailed biochemical and functional studies of three mutant K-Ras proteins (P34R, D153V, and F156L) found in individuals with Noonan syndrome and cardiofaciocutaneous syndrome.
|
17875937 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
We further defined the phenotypic spectrum associated with KRAS missense mutations and provided the first evidence of clinical differences in patients with KRAS mutations compared with Noonan syndrome affected individuals with heterozygous PTPN11 mutations and CFC patients carrying a BRAF, MEK1 or MEK1 alteration, respectively.
|
17056636 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
CFCS is genetically heterogeneous and mutations in the KRAS, BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2) genes, encoding for components of the RAS-mitogen activated protein kinase (MAPK) signaling pathway, have been identified in up to 90% of cases.
|
19156172 |
2009 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Germline KRAS mutations cause Noonan syndrome.
|
16474405 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We have observed unusual transverse distal phalangeal creases in two patients, one with Costello syndrome (G12S mutation in the HRAS gene) and one with cardio-facio-cutaneous (CFC) syndrome or possibly Noonan syndrome (Q22E mutation in the KRAS gene).
|
17324647 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Mutations were identified in seven patients with CFC (two in BRAF, one in KRAS, one in MEK1, two in MEK2 and one in SOS1).
|
18456719 |
2008 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We and others recently discovered novel germline KRAS mutations in individuals diagnosed with Noonan or cardio-facio-cutanous (CFC) syndrome, two clinically overlapping disorders characterized by short stature, distinct facial anomalies, heart defects, and other developmental abnormalities.
|
16921267 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
|
21797849 |
2012 |